Presentation of cytosolically stable peptides by HLA-B27 is not dependent on the canonic interactions of N-terminal basic residues in the a pocket

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 446-455

  Gómez, Patricia ^a   Mavian, Carla ^a   Galocha, Begoña ^a   García Medel, Noel ^a   López De Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; GLUTAMIC ACID; HLA B 2705 ANTIGEN; HLA B ANTIGEN; HLA-B 2705 ANTIGEN; LIGAND; PEPTIDE FRAGMENT; SERINE; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN STABILITY; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; BIOSYNTHESIS; CYTOSOL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; PH; PROTEIN BINDING; SIGNAL TRANSDUCTION; THERMODYNAMICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; CELL LINE, TUMOR; CYTOSOL; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HLA-B ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; LIGANDS; PEPTIDE FRAGMENTS; PROTEIN BINDING; SERINE; SIGNAL TRANSDUCTION; THERMODYNAMICS; THREONINE; TRYPTOPHAN;

EID: 59849128475     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.446     Document Type: Article

References (44)

1. Brewerton, D. A., F. D. Hart, A. Nicholls, M. Caffrey, D. C. James, and R. D. Sturrock. 1973. Ankylosing spondylitis and HL-A 27. Lancet 1: 904-907.
2. Brewerton, D. A., M. Caffrey, A. Nicholls, D. Walters, J. K. Oates, and D. C. James. 1973. Reiter's disease and HL-A 27. Lancet 2: 996-998.
3. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11: 137-142.
4. Marcilla, M., and J. A. Lopez de Castro. 2008. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 71: 495-506.
5. Gomard, E., M. Sitbon, A. Toubert, B. Begue, and J. P. Levy. 1984. HLA-B27, a dominant restricting element in antiviral responses? Immunogenetics 20: 197-204.
6. McNeil, A. J., P. L. Yap, S. M. Gore, R. P. Brettle, M. McColl, R. Wyld, S. Davidson, R. Weightman, A. M. Richardson, and J. R. Robertson. 1996. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Q. J. Med. 89: 177-185.
7. Kelleher, A. D., C. Long, E. C. Holmes, R. L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, et al. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193: 375-386.
8. den Uyl, D., I. E. van der Horst-Bruinsma, and M. van Agtmael. 2004. Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Rev. 6: 89-96.
9. Schneidewind, A., M. A. Brockman, J. Sidney, Y. E. Wang, H. Chen, T. J. Suscovich, B. Li, R. I. Adam, R. L. Allgaier, B. R. Mothe, et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82: 5594-5605.
10. + T cell response in mediating HCV clearance and evolution. Hepatology 43: 563-572.
11. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353: 326-329.
12. Lopez de Castro, J. A., I. Alvarez, M. Marcilla, A. Paradela, M. Ramos, L. Sesma, and M. Vazquez. 2004. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 63: 424-445.
13. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70: 1035-1048.
14. Villadangos, J. A., B. Galocha, F. Garcia, J. P. Albar, and J. A. Lopez de Castro. 1995. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur. J. Immunol. 25: 2370-2377.
15. Lamas, J. R., A. Paradela, F. Roncal, and J. A. Lopez de Castro. 1999. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum. 42: 1975-1985.
16. Hillig, R. C., M. Huelsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler. 2004. Thermodynamic and structural analysis of peptide-and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 279: 652-663.
17. Herberts, C. A., J. J. Neijssen, J. de Haan, L. Janssen, J. W. Drijfhout, E. A. Reits, and J. J. Neefjes. 2006. Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J. Immunol. 176: 2697-2701.
18. Zemmour, J., A. M. Little, D. J. Schendel, and P. Parham. 1992. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148: 1941-1948.
19. Calvo, V., S. Rojo, D. Lopez, B. Galocha, and J. A. Lopez de Castro. 1990. Structure and diversity of HLA-B27-specific T cell epitopes: analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J. Immunol. 144: 4038-4045.
20. Villadangos, J. A., B. Galocha, D. Lopez, V. Calvo, and J. A. Lopez de Castro. 1992. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition. J. Immunol. 149: 505-510.
21. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14: 9-20.
22. Ellis, S. A., C. Taylor, and A. McMichael. 1982. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum. Immunol. 5: 49-59.
23. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
24. 2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum. 52: 3290-3299.
25. Paradela, A., M. Garcia-Peydro, J. Vazquez, D. Rognan, and J. A. Lopez de Castro. 1998. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J. Immunol. 161: 5481-5490.
26. Paradela, A., I. Alvarez, M. Garcia-Peydro, L. Sesma, M. Ramos, J. Vazquez, and J. A. Lopez de Castro. 2000. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J. Immunol. 164: 329-337.
27. Marina, A., M. A. Garcia, J. P. Albar, J. Yague, J. A. Lopez de Castro, and J. Vazquez. 1999. High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry. J. Mass Spectrom. 34: 17-27.
28. Merino, E., B. Galocha, M. Vázquez, and J. A. López de Castro. 2008. Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis. Rheum. 58: 3693-3703.
29. Sesma, L., V. Montserrat, J. R. Lamas, A. Marina, J. Vazquez, and J. A. Lopez de Castro. 2002. The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. J. Biol. Chem. 277: 16744-16749.
30. Ramos, M., A. Paradela, M. Vazquez, A. Marina, J. Vazquez, and J. A. Lopez de Castro. 2002. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J. Biol. Chem. 277: 28749-28756.
31. Gomez, P., V. Montserrat, M. Marcilla, A. Paradela, and J. A. López de Castro. 2006. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis. Eur. J. Immunol. 36: 1867-1881.
32. Merino, E., V. Montserrat, A. Paradela, and J. A. Lopez de Castro. 2005. Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity, but have limited peptide and T-cell epitope sharing with HLA-B27. J. Biol. Chem. 280: 35868-35880.
33. Marcilla, M., J. J. Cragnolini, and J. A. Lopez de Castro. 2007. Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins. Mol. Cell. Proteomics 6: 923-938.
34. Garrett, T. P., M. A. Saper, P. J. Bjorkman, J. L. Strominger, and D. C. Wiley. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342: 692-696.
35. Yewdell, J. W., E. Reits, and J. Neefjes. 2003. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3: 952-961.
36. Princiotta, M. F., D. Finzi, S. B. Qian, J. Gibbs, S. Schuchmann, F. Buttgereit, J. R. Bennink, and J. W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
37. Reits, E., A. Griekspoor, J. Neijssen, T. Groothuis, K. Jalink, P. van Veelen, H. Janssen, J. Calafat, J. W. Drijfhout, and J. Neefjes. 2003. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18: 97-108.
38. Yague, J., M. Ramos, J. Vazquez, A. Marina, J. P. Albar, and J. A. Lopez de Castro. 1999. The South Amerindian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA- B27. Tissue Antigens 53: 227-236.
39. Urvater, J. A., H. Hickman, J. L. Dzuris, K. Prilliman, T. M. Allen, K. J. Schwartz, D. Lorentzen, C. Shufflebotham, E. J. Collins, D. L. Neiffer, et al. 2001. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2. J. Immunol 166: 3334-3344.
40. Fremont, D. H., M. Matsumura, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1992. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257: 919-927.
41. Frederick, K. K., M. S. Marlow, K. G. Valentine, and A. J. Wand. 2007. Conformational entropy in molecular recognition by proteins. Nature 448: 325-329.
42. Zhou, P., X. Chen, and Z. Shang. 2009. Side-chain conformational space analysis (SCSA): a multi conformation-based QSAR approach for modeling and prediction of protein-peptide binding affinities. J. Comput. Aided Mol. Des. In press.
43. Hülsmeyer, M., R. C. Hilling, A. Volz, M. Rühl, W. Schröder, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2002. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 277: 47844-47853.
44. Williams, A. P., C. A. Peh, A. W. Purcell, J. McCluskey, and T. Elliott. 2002. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520.